Wheat having increased resistance to imidazolinone herbicides

Details for Australian Patent Application No. 2002322212 (hide)

Owner University of Saskatchewan

Inventors Hucl, Pierre

Agent Pizzeys

Pub. Number AU-B-2002322212

PCT Number PCT/CA02/01050

PCT Pub. Number WO2003/014356

Priority 60/311,180 09.08.01 US

Filing date 10 July 2002

Wipo publication date 24 February 2003

Acceptance publication date 5 June 2008

International Classifications

C12N 15/60 (2006.01) Mutation or genetic engineering - Lyases (4)

A01H 5/00 (2006.01) Products

A01H 5/10 (2006.01) Products - Seeds

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/311,180 09.08.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002322212

5 June 2008 Application Accepted

  Published as AU-B-2002322212

21 August 2008 Corrigenda

  Applications Accepted - Name Index Under the name University of Saskatchewan, Application No. 2002322212, under INID(54), correct the invention title to Wheat plants having increased resistance to imidazolinone herbicides

2 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322213-TREATMENT OF MACULAR EDEMA WITH PHOTODYNAMIC THERAPY

2002322211-METHODS AND COMPISITIONS FOR MODULATING THE SIMULATION OF HUMAN T CELLS IN VITRO AND IMPLICATIONS THEREOF FOR THERAPEUTIC STRATEGIES EX VIVO AND IN VIVO